Avoid common mistakes on your manuscript.
Dear Reader,
Welcome to the final issue of Drugs in R&D for 2023.
I would like to reflect on this year’s achievements and to thank all those who have contributed their valuable time and effort to the journal over the past 12 months.
I would like to start by thanking the authors of the articles published in Drugs in R&D over the course of 2023. The skill and dedication of these experts is critical to the continued success of the journal.
The high quality of articles published in the journal has been reflected in the most recent Impact Factor of 3.0 and CiteScore of 5.2.
I gratefully acknowledge all of the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
G. An, University of Iowa, Iowa, IA, USA
S. Ballet, Vrije Universiteit Brussel, Brussels, Belgium
S. Bellino, Centro Nazionale per la Ricerca, Rome, Italy
D. Cattaneo, Luigi Sacco University Hospital, Milan, Italy
S. Cheli, Luigi Sacco University Hospital, Milan, Italy
G. Cherala, Eastern Virginia Medical School, Norfolk, VA, USA
P.G. Cojutti, University of Udine, Udine, Italy
D. Danielak, Poznan University of Medical Science, Poznan, Poland
R.P. Dash, Johns Hopkins School of Medicine, Baltimore, MD, USA
M.A. Diniz, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA
K. Dua, University of Technology Sydney, Sydney, NSW, Australia
H. Fukase, Clinical Research Hospital Tokyo, Tokyo, Japan
R. Giusti, Sant'Andrea Hospital of Rome, Rome, Italy
I. Grabnar, University of Ljubljana, Ljubljana, Slovenia
C. Guillén-Ponce, Hospital Universitario Ramón y Cajal, Madrid, Spain
Y.K. Gupta, All India Institute of Medical Sciences, New Delhi, India
H.P. Hartung, Heinrich-Heine University, Dusseldorf, Germany
C. Höcht, University of Buenos Aires, Buenos Aires, Argentina
F. Jamali, University of Alberta, Edmonton, AB, Canada
G.A. Keller, University of Buenos Aires, Buenos Aires, Argentina
T.K.L. Kiang, The University of British Columbia, Vancouver, BC, Canada
M.J. McKeage, University of Auckland, Auckland, New Zealand
S. Mercadante, La Maddalena Cancer Center, Palermo, Italy
S. Misaka, Fukushima Medical University, Fukushima, Japan
P.J. Nathan, Monash University, Melbourne, VIC, Australia
J. Niu, FDA*, Silver Spring, MD, USA
F.J. Otero-Espinar, University of Santiago de Compostela, Santiago de Compostela, Spain
B.M. Patel, Nirma University, Ahmedabad, India
S. Perez-Lloret, Institute for Cardiology Research, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina
M. Pfister, University of Basel, Basel, Switzerland
V.P. Ranta, University of Eastern Finland, Kuopio, Finland
G. Remington, University of Toronto, Toronto, ON, Canada
Y. Saisho, Keio University School of Medicine, Tokyo, Japan
G.M.L. Santos, Brazilian Health Regulatory Agency, Brasilia, Brazil
H. Schütz, BEBAC Consulting, Vienna, Austria
D.R. Serrano, Complutense University of Madrid, Madrid, Spain
M.H. Shishehbor, Cleveland Clinic Cardiovascular Disease, Cleveland, OH, USA
L.P. Shulman, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA
G. Singhania, CHI St. Vincent Infirmary, Little Rock, AK, USA
O. Slanař, Charles University, Prague, Czech Republic
A.G. Solano, Federal University of São João del-Rei, São João del-Rei, Brazil
L. Tóthfalusi, Semmelweis University, Budapest, Hungary
T. Van Duong, Purdue University, West Lafayette, IN, USA
M. Vissers, Centre for Human Drug Research, Leiden, The Netherlands
K. Vučićević, University of Belgrade, Belgrade, Serbia
J. Weiss, University of Heidelberg, Heidelberg, Germany
S. Yamada, Diabetes Center, Kitasato Institute Hospital, Tokyo, Japan
The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would therefore like to thank the following individuals who acted as reviewers for Drugs in R&D in the last 12 months:
Gianmarco Abbadessa, Italy
Claudia Altamura, Italy
Benny Amore, USA
Andreas Argyriou, Greece
Alain Astier, France
Ruggero Bacchin, Italy
Sagar S. Bachhav, USA
Maria A. Barbieri, Italy
Semih Başcı, Turkey
Cecilia Bender, Germany
Alexander Broomfield, UK
Andrea Buchacher, Austria
Adam Buckley, United Arab Emirates
Cherie Butts, USA
John G. Coghlan, UK
Paola Dell'Albani, Italy
Yomna Elleithi, Egypt
Michael Etscheid, Germany
Udoamaka Ezuruike, UK
Trine Frederiksen, Denmark
Anders Fuglsang, Denmark
Janice Garcia-Quiroz, Mexico
Nicola Gelbmann, Austria
Mohammed Ghazwani, Saudi Arabia
Parag Goyal, USA
Henry G. Grabowski, USA
Karin Hedenmalm, the Netherlands
Vincent Ho, Australia
Debasish Hota, India
Jie Huang, China
Slobodan M. Jankovic, Serbia
Anselm Jorda, Austria
Shohei Kikuchi, Japan
Csongor Kiss, Hungary
Daan Kremer, the Netherlands
Daan Lanser, the Netherlands
Anders Larsson, Sweden
Huiping Li, China
Li Liu, China
Xiao-Dong Liu, China
Ibrahim Mahmoud, USA
Daniel C. Malone, USA
Catia Marzolini, Switzerland
Luca Mastorino, Italy
Matteo Megna, Italy
Karolina Mėlinytė-Ankudavičė, Lithuania
Aleksander Mendyk, Poland
Brittany Merrill, USA
Milijana N. Miljković, Serbia
Toshihide Mimura, Japan
Barney Mitton, South Africa
Donald Moore, USA
Ryan Morgan, USA
Joanna J. Moser, Canada
Agata Mulak, Poland
Renato R.P. Munhoz, Canada
Natalia Navas, Spain
Jessica Nunes, USA
Hironao Okubo, Japan
Alexis Oliva, Spain
Federico Olivieri, Italy
Joshua Osowicki, Australia
Vasiliki Pantazou, France
Sathishbabu Paranthaman, India
Raquel Perez-Robles, Spain
Laure Peyro-Saint-Paul, France
JoAnn V. Pinkerton, USA
Donald Poirier, Canada
Efstathia Polychronopoulou, USA
Andrea Pozzi, Italy
Diane Ramsden, USA
Richard Riker, USA
Gaël Roué, Spain
Piero Ruscitti, Italy
Wojciech Rzechorzek, USA
Farshid Sadeghipour, Switzerland
Muhammad N.A. Sahid, Indonesia
Joshua H. Santos, Philippines
Vladimir Savransky, USA
Laila Selim, Egypt
Swapnil Sharma, India
Gauri Shishodia, USA
Stephen Shrewsbury, USA
Cristiana Sieiro Santos, Spain
Ravi S.P. Singh, USA
Karin Sipido, Belgium
Jakob Skov, Sweden
Frank Z. Stanczyk, USA
Isharyah Sunarno, Indonesia
Shindu Thomas, USA
Daniel J. Touw, the Netherlands
Jan-Alexis Tremblay, Canada
Karen Vertessen, the Netherlands
Karthick Vishwanathan, UK
Oliver von Richter, Germany
Chuang-Wei Wang, Taiwan, Republic of China
Thomas Wendl, Germany
Elena R. Wolff-Holz, Germany
Hongju Wu, USA
Ikuo Yamamiya, Japan
Gülbeyaz Yildiz Türkyilmaz, Turkey
Takashi Yoshikado, Japan
I hope that you have found the articles published throughout 2023 to be both interesting and informative. I have appreciated the high quality of content contributed to the journal and we look forward to keeping you up to date with topical issues in 2024.
With best wishes from the Editor of Drugs in R&D.
Anton van Rensburg
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Acknowledgement to Referees. Drugs R D 23, 297–299 (2023). https://doi.org/10.1007/s40268-023-00447-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40268-023-00447-1